Lv31
332 积分 2025-01-20 加入
Discovery of Zoldonrasib (RMC-9805), a Potent and Orally Bioavailable RAS(ON) G12D-Selective, Covalent, Tri-Complex Inhibitor for the Treatment of Patients with RAS G12D-Addicted Cancers
4小时前
已完结
Mining the CRBN target space redefines rules for molecular glue–induced neosubstrate recognition
1个月前
已完结
Deep lead optimization enveloped in protein pocket and its application in designing potent and selective ligands targeting LTK protein
1个月前
已完结
Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth
1个月前
已完结
Selective Macrocyclic WEE1 Kinase Inhibitors with Strong Efficacy against Patient-Derived Colorectal Cancer Organoids
2个月前
已完结
MolT5-Linker: A Transformer-Based Sequence- and Putative Site-Guided Generative Framework for Antibody-Drug Conjugate Linkers
2个月前
已完结
Artificial intelligence in antibody design and development: harnessing the power of computational approaches
3个月前
已完结
A new era of antibody discovery: an in-depth review of AI-driven approaches
3个月前
已完结
Machine learning for functional protein design
3个月前
已完结
Multi-objective antibody design and optimization using machine learning
3个月前
已完结
皖公网安备34019202002308
